By Stefan Gafner and Mark Blumenthal, American Botanical Council
The news about CBD and hemp extracts dominated 2019, says the American Botanical Council. But issues surrounding the ongoing climate crisis, questions of sustainability, and the ongoing questions of adulteration were important topics as well.
Georgia-based Purisys is “looking forward to the opportunity” in food, beverage and nutraceuticals after the U.S. Drug Enforcement Agency removed its cannabidiol (CBD) from Schedule I of the Controlled Substances Act.
By Michael McGuffin, president, American Herbal Products Association
Questions surrounding the hemp/CBD trade, a recognition of the continued popularity of herbal supplements, and a casting a wary eye toward regulatory creep topped the list of 2019 concerns for the American Herbal Products Association.
An interim federal government funding measure does not include language creating a legal pathway for hemp/CBD products, despite advocacy on the part of stakeholders including lawmakers and trade organizations.
By Daniel Fabricant, PhD, CEO and President of the Natural Products Association (NPA)
2019 will be remembered as the year Cannabidiol (CBD) hit the American mainstream. From Ben and Jerry’s Ice Cream to pet food and hand lotions to vape pens, CBD is everywhere we look. Which is why it is easy to understand why the majority of Americans...
Recent statements and actions by the US Food and Drug Administration (FDA) regarding CBD have spurred four of the dietary supplement industry’s trade association to write Congress urging them to take quick action.
The dietary supplement industry is a crazy quilt that marries the sublime to the ridiculous and includes players of the highest moral and intellectual standards as well as those participating in the basest grubbing for money.
New York State recently put into place regulations that govern hemp cultivation within its borders. In addition, the new law creates a regulatory framework specific to the trade in cannabinoid extracts and finished goods.
It was only a matter of time before the plaintiff’s bar sought to cash in on the legal uncertainty surrounding cannabidiol (CBD), say attorneys. So how might brands defend themselves against the latest wave of lawsuits, which argue that their products...